These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 25566357
1. A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groups. Khan A, Yavorsky C, Liechti S, Opler M, Rothman B, DiClemente G, Lucic L, Jovic S, Inada T, Yang L. BMC Psychol; 2013; 1(1):5. PubMed ID: 25566357 [Abstract] [Full Text] [Related]
2. Meta-analysis of the positive and Negative Syndrome Scale (PANSS) factor structure. Shafer A, Dazzi F. J Psychiatr Res; 2019 Aug; 115():113-120. PubMed ID: 31128501 [Abstract] [Full Text] [Related]
3. Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural Consistency. Khan A, Liharska L, Harvey PD, Atkins A, Ulshen D, Keefe RSE. Innov Clin Neurosci; 2017 Dec 01; 14(11-12):30-40. PubMed ID: 29410935 [Abstract] [Full Text] [Related]
8. [Identification by typological analysis of distinct groups of schizophrenic patients. Applicability of a disorganized schizophrenia subtype]. Brazo P, Ribeyre JM, Petit M, Dollfus S. Encephale; 1996 Dec 01; 22(3):165-74. PubMed ID: 8767044 [Abstract] [Full Text] [Related]
10. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia. Sarró S, Dueñas RM, Ramírez N, Arranz B, Martínez R, Sánchez JM, González JM, Saló L, Miralles L, San L. Schizophr Res; 2004 Jun 01; 68(2-3):349-56. PubMed ID: 15099616 [Abstract] [Full Text] [Related]
11. Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia. Citrome L, Du Y, Risinger R, Stankovic S, Claxton A, Zummo J, Bose A, Silverman BL, Ehrich EW. Int Clin Psychopharmacol; 2016 Mar 01; 31(2):69-75. PubMed ID: 26517202 [Abstract] [Full Text] [Related]
12. Assessing the sources of unreliability (rater, subject, time-point) in a failed clinical trial using items of the Positive and Negative Syndrome Scale (PANSS). Khan A, Yavorsky WC, Liechti S, DiClemente G, Rothman B, Opler M, DeFries A, Jovic S. J Clin Psychopharmacol; 2013 Feb 01; 33(1):109-17. PubMed ID: 23277234 [Abstract] [Full Text] [Related]
14. Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models. Baandrup L, Allerup P, Nielsen MØ, Düring SW, Bojesen KB, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Díaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, Fleischhacker WW, Kahn RS, Glenthøj BY. Acta Psychiatr Scand; 2022 Jul 01; 146(1):21-35. PubMed ID: 35417039 [Abstract] [Full Text] [Related]
15. How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS. Cruz BF, de Resende CB, Abreu MN, Rocha FL, Teixeira AL, Keefe RS, Salgado JV. Cogn Neuropsychiatry; 2013 May 01; 18(3):243-51. PubMed ID: 23145794 [Abstract] [Full Text] [Related]
18. Application of Rasch analysis to examine psychometric aspects of the activities-specific balance confidence scale when used in a new cultural context. Arnadottir SA, Lundin-Olsson L, Gunnarsdottir ED, Fisher AG. Arch Phys Med Rehabil; 2010 Jan 01; 91(1):156-63. PubMed ID: 20103411 [Abstract] [Full Text] [Related]